Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood

被引:340
作者
Lee, MM
Donahoe, PK
Hasegawa, T
Silverman, B
Crist, GB
Best, S
Hasegawa, Y
Noto, RA
Schoenfeld, D
MacLaughlin, DT
机构
[1] MASSACHUSETTS GEN HOSP, PEDIAT ENDOCRINE UNIT, BOSTON, MA 02114 USA
[2] MASSACHUSETTS GEN HOSP, CTR BIOSTAT, BOSTON, MA 02114 USA
[3] TOKYO METROPOLITAN KIYOSE CHILDRENS HOSP, DIV ENDOCRINOL & METAB, TOKYO, JAPAN
[4] CHILDRENS MEM HOSP, DEPT PEDIAT ENDOCRINOL & DIABET, CHICAGO, IL 60614 USA
[5] NEW YORK MED COLL, DEPT PEDIAT ENDOCRINOL, VALHALLA, NY 10595 USA
关键词
D O I
10.1210/jc.81.2.571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mullerian inhibiting substance (MIS) is a gonadal hormone synthesized by Sertoli cells of the testis and granulosa cells of the ovary. To facilitate the use of MIS for the evaluation of intersex disorders and as a tumor marker in women with MIS-expressing ovarian tumors, we measured MIS in 600 serum samples from males and females. These data show that mean MIS values for males rise rapidly during the first year of life and are highest during late infancy, then gradually decline until puberty. In contrast, MIS values in females are lowest at birth and exhibit a minimal increase throughout the prepubertal years. Whereas MIS is uniformly measurable in all prepubertal boys studied, it is undetectable in most prepubertal female subjects. These data reveal an easily discernible sexually dimorphic pattern of expression and confirm that MIS can be used as a testis-specific marker during infancy and early childhood. MIS values that are above the upper limits for females are discriminatory for the presence of testicular tissue or ovarian tumor, and those below the lower limits for males are consistent with dysgenetic or absent testes or the presence of ovarian tissue. These data will enable normal and abnormal levels of MIS to be differentiated with higher precision and will facilitate the use of MIS in the management of gonadal disorders.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 24 条
[1]   SERUM LEVELS OF MULLERIAN INHIBITING SUBSTANCE IN BOYS FROM BIRTH TO 18 YEARS, AS DETERMINED BY ENZYME-IMMUNOASSAY [J].
BAKER, ML ;
METCALFE, SA ;
HUTSON, JM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (01) :11-15
[2]  
BEZARD J, 1987, J REPROD FERTIL, V80, P509, DOI 10.1530/jrf.0.0800509
[3]   MULLERIAN INHIBITING SUBSTANCE AS A MARKER FOR OVARIAN SEX-CORD TUMOR [J].
GUSTAFSON, ML ;
LEE, MM ;
SCULLY, RE ;
MONCURE, AC ;
HIRAKAWA, T ;
GOODMAN, A ;
MUNTZ, HG ;
DONAHOE, PK ;
MACLAUGHLIN, DT ;
FULLER, AF .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (07) :466-471
[4]   MULLERIAN INHIBITING SUBSTANCE IN THE DIAGNOSIS AND MANAGEMENT OF INTERSEX AND GONADAL ABNORMALITIES [J].
GUSTAFSON, ML ;
LEE, MM ;
ASMUNDSON, L ;
MACLAUGHLIN, DT ;
DONAHOE, PK .
JOURNAL OF PEDIATRIC SURGERY, 1993, 28 (03) :439-444
[5]   MULLERIAN INHIBITING SUBSTANCE MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN GRANULOSA AND SERTOLI CELLS COINCIDES WITH THEIR MITOTIC-ACTIVITY [J].
HIROBE, S ;
HE, WW ;
LEE, MM ;
DONAHOE, PK .
ENDOCRINOLOGY, 1992, 131 (02) :854-862
[6]   AN IMMUNOASSAY TO DETECT HUMAN MULLERIAN INHIBITING SUBSTANCE IN MALES AND FEMALES DURING NORMAL DEVELOPMENT [J].
HUDSON, PL ;
DOUGAS, I ;
DONAHOE, PK ;
CATE, RL ;
EPSTEIN, J ;
PEPINSKY, RB ;
MACLAUGHLIN, DT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (01) :16-22
[7]  
JOSSO N, 1993, RECENT PROG HORM RES, V48, P1
[8]   ANTI-MULLERIAN HORMONE AND INTERSEX STATES [J].
JOSSO, N ;
BOUSSIN, L ;
KNEBELMANN, B ;
NIHOULFEKETE, C ;
PICARD, JY .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1991, 2 (06) :227-233
[9]   AN ENZYME LINKED IMMUNOASSAY FOR ANTI-MULLERIAN HORMONE - A NEW TOOL FOR THE EVALUATION OF TESTICULAR FUNCTION IN INFANTS AND CHILDREN [J].
JOSSO, N ;
LEGEAI, L ;
FOREST, MG ;
CHAUSSAIN, JL ;
BRAUNER, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (01) :23-27
[10]  
Jost A., 1947, ARCH ANAT MICR MORPH, V36, P271